REAL-WORLD CLINICAL OUTCOMES WITH FIRST-LINE SYSTEMIC TREATMENT AND AVELUMAB MAINTENANCE IN US PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA: THE SPEAR BLADDER-II STUDY
Account has been disabled due to a violation of Terms of Service.